Clinical Trials Browser

Phase 2/3 × Has results × Olanzapine × Clear all

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Phase 2/3 Completed

30 enrolled 9 charts

Nausea, Vomiting